No.

Publication Date

Citing Article

1

2025

Junming Sun, Bin Huang, Weikun Zhao, Qiurui Li, Siwei Yin, Ying Zhang, Rongjie Huang. Prevalence of dyslipidemia and its associated risk factors in hypertensive population: A single-center cross-sectional study in southern China, Journal of the Renin-Angiotensin-Aldosterone System. 2025; 26: 14703203251353658.  https://doi.org/10.1177/14703203251353658

2

2025

Kadir Yeşildal, Fethi Gültop, Cansu Kılınç Berktaş, Müslüm Akkılıç, Namigar Turgut. The impact of insulin requirement on mortality and morbidity in non-diabetic covid-19 patients in the intensive care unit: A retrospective, observational study, BMC Anesthesiology. 2025; 25: 160.  https://doi.org/10.1186/s12871-025-03037-7

3

2025

Huda Jassim Muhammad, Radhwan M. Hussein, Muntadher Zmezim, Ali Fawzi Al‑Hussainy, Haneen Hussein Farhood, Iman Hussein Naser, Hamid Alghurabi. Predictors of insulin adherence among patients with type 2 diabetes: a cross-sectional study, Current Medical Research and Opinion. 2025; 1.  https://doi.org/10.1080/03007995.2025.2517697

4

2025

Chiara Grasselli, Maicol Baldini, Lucia Salvi, Grazia Vestita, Maurizio Zizzo, Davide Felaco, Maria Carolina Balli, Giulia Besutti, Aurelio Negro, Angelo Ghirarduzzi. Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism, Diseases. 2025; 13: 52.  https://doi.org/10.3390/diseases13020052

5

2025

Ziqi Chen, Iokfai Cheang, Xu Zhu, Qiang Qu, Sitong Chen, Yutong Xing, Yanli Zhou, Haifeng Zhang, Xinli Li. Associations of body roundness index with cardiovascular disease and mortality among patients with metabolic syndrome, Diabetes, Obesity and Metabolism. 2025; 27: 3285.  https://doi.org/10.1111/dom.16346

6

2025

Yun Soo Lee, Goeun Park, Kyungho Lee, Hye Ryoun Jang, Jung Eun Lee, Wooseong Huh, Junseok Jeon. SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index, BMJ Open Diabetes Research & Care. 2025; 13: e004876.  https://doi.org/10.1136/bmjdrc-2024-004876

7

2025

Kengo Miyoshi, Tomohisa Aoyama, Saori Kameda, Nagisa Ishibashi, Yumi Sakai, Takao Yamanaka, Tomoya Kawaguchi, Yuri Kadowaki, Toshimasa Yamauchi. Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study, Journal of Diabetes and its Complications. 2025; 39: 109068109068.  https://doi.org/10.1016/j.jdiacomp.2025.109068

8

2025

Yuxuan Xun, Gang Hu. Trends in high remnant cholesterol level and its risk factors among US adults using NHANES data from 1999 to 2020: a serial cross-sectional study, BMJ Open. 2025; 15: e095079.  https://doi.org/10.1136/bmjopen-2024-095079

9

2025

Paolo Magni, Tijana Mitić, Yvan Devaux, Philippe Pierre, Miron Sopić, Fernando de la Cuesta, Rui Vitorino. Deciphering immune dynamics in atherosclerosis: Inflammatory mediators as biomarkers and therapeutic target, European Journal of Clinical Investigation. 2025; 55: e70043.  https://doi.org/10.1111/eci.70043

10

2025

Samuel Idowu Fayomi, Ochuko Lucky Erukainure, Nontokozo Zimbili Msomi. The Essentiality of Amino Acids in Healthiness and Disease State: Type II Diabetes as a Case Study, Food Science & Nutrition. 2025; 13: e70346.  https://doi.org/10.1002/fsn3.70346

11

2025

Kenni Wojujutari Ajele, Elmari Deacon. Targeting depression and diabetes comorbidity: A generalization meta-analysis of randomized controlled trials on cognitive-behavioural therapy efficacy, Primary Care Diabetes. 2025; 19: 93.  https://doi.org/10.1016/j.pcd.2025.01.004

12

2025

Qi Feng, Chioma N. Izzi‐Engbeaya, Pinelopi Manousou, Mark Woodward. Obesity drives the link between liver fat and depression: Cross‐sectional and prospective investigations, Diabetes, Obesity and Metabolism. 2025; dom.16562.  https://doi.org/10.1111/dom.16562